Cargando…
Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
Breast cancer can occur in either gender; however, it is rare in men, accounting for <1% of diagnosed cases. In a previous transcriptomic screen of male breast cancer (MBC) and female breast cancer (FBC) occurrences, we observed that Stanniocalcin 2 (STC2) was overexpressed in the former. The aim...
Autores principales: | Coulson‐Gilmer, Camilla, Humphries, Matthew P, Sundara Rajan, Sreekumar, Droop, Alastair, Jackson, Sharon, Condon, Alexandra, Cserni, Gabor, Jordan, Lee B, Jones, Louise J, Kanthan, Rani, Di Benedetto, Anna, Mottolese, Marcella, Provenzano, Elena, Kulka, Janina, Shaaban, Abeer M, Hanby, Andrew M, Speirs, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174618/ https://www.ncbi.nlm.nih.gov/pubmed/29956502 http://dx.doi.org/10.1002/cjp2.106 |
Ejemplares similares
-
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
por: Humphries, Matthew P., et al.
Publicado: (2017) -
HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes
por: Di Benedetto, Anna, et al.
Publicado: (2016) -
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
por: Benedetto, Anna Di, et al.
Publicado: (2016) -
Problems (and solutions) in the study of male breast cancer
por: Speirs, Valerie, et al.
Publicado: (2010) -
Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022)